N-Glycolylneuraminic acid
USP/1294284 - United States Pharmacopeia (USP) Reference Standard
Synonym: 3,5-
CAS Number: 1113-83-3
Empirical Formula (Hill Notation): C11H19NO10
Molecular Weight: 325.27
MDL Number: MFCD00057551
Linear Formula: C11H19NO10
Product Type: Chemical
| API family | sialic acid |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| form | powder |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C11H19NO10/c13-2-5(16) |
| InChI key | FDJKUWYYUZCUJX-AJKRCSPLSA |
| manufacturer/tradename | USP |
| SMILES string | [H][C@]1(O[C@@](O)(C[C@H] |
| storage temp. | −20°C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | N-Glycolylneuraminic acid USP reference standard in specified compendial tests and assays. Also used to prepare standard stock solutions during monosaccharide analysis and analytical procedures for monoclonal antibodies and subtypes according to the given below general chapters of United States Pharmacopeia (USP): • 〈210〉 Monosaccharide analysis • 〈129〉 Analytical procedures for recombinant therapeutic monoclonal antibodies |
| General description: | This compound is a sialic acid derivative important in various biological processes and is used in research related to glycoproteins. The USP biologics monoclonal antibodies (mAb) category includes a range of therapeutic proteins that are designed to target specific antigens, providing effective treatments for various diseases, including cancers and autoimmune disorders. Monoclonal antibodies are produced using hybridoma technology and are essential in both diagnostics and therapeutics. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of monoclonal antibody products throughout their lifecycle. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of the USP Biologics program. |
| Other Notes: | This product is part of USP Biologics Program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 41116107 |

